AstraZeneca PLC (LON:AZN)
London · Delayed Price · Currency is GBP · Price in GBX 11,708
-50 (-0.43%)
Sep 11, 2026, 4:55 PM GMT
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of 182.37 billion as of September 11, 2026. Its market cap has decreased by -1.29% in one year.
Market Cap
182.37B
Enterprise Value
203.06B
Revenue
46.25B
Ranking
n/a
PE Ratio
23.35
Stock Price
11,708.00
ChartMarket Cap Chart
Since May 28, 1993, AstraZeneca's market cap has increased from 4.55B to 182.37B, an increase of 3,907.77%. That is a compound annual growth rate of 11.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 182.37B | -14.72% |
| Dec 31, 2025 | 213.85B | 31.77% |
| Dec 31, 2024 | 162.29B | -1.22% |
| Dec 29, 2023 | 164.29B | -5.48% |
| Dec 30, 2022 | 173.83B | 29.30% |
| Dec 31, 2021 | 134.44B | 39.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GSK plc | 72.27B |
| Haleon | 29.49B |
| Smith & Nephew | 8.63B |
| Convatec Group | 4.32B |
| Hikma Pharmaceuticals | 3.23B |
| HUTCHMED (China) | 1.76B |
| Oxford Nanopore Technologies | 1.54B |
| Genus | 1.49B |